Entrada Therapeutics Growth Metrics (2021-2026) | TRDA

Growth Metrics Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) 5,982.0020,272.00-14730.002,147.00-12105.00-227033.00-265570.00-301286.00-450343.00
EBITDA Margin Growth (3y) (Quarter) -456467.00
EBITDA Margin (QoQ) (Quarter) -12388.0022,694.00-10340.006,015.001,903.00-12308.006,536.00-8237.00-213025.00-50845.00-29179.00-157294.00
EBIT Margin Growth (1y) (Quarter) 5,859.0014,612.00-14271.00-2741.00-14170.00-245893.00-280451.00-323358.00-472864.00
EBIT Margin Growth (3y) (Quarter) -481175.00
EBIT Margin (QoQ) (Quarter) -6682.0012,174.00-2032.002,399.002,070.00-16709.009,498.00-9030.00-229652.00-51267.00-33409.00-158536.00
EBT Margin Growth (1y) (Quarter) 5,520.0012,752.00-12251.00-2406.00-12723.00-226231.00-261272.00-300588.00-445035.00
EBT Margin Growth (3y) (Quarter) -452238.00
EBT Margin (QoQ) (Quarter) -5413.0010,779.00-1922.002,076.001,819.00-14223.007,923.00-8241.00-211689.00-49265.00-31392.00-152689.00
Enterprise Value Growth (1y) (Quarter) -645.46%-76.41%84.49%13.74%67.35%75.93%-49.70%69.94%-132.31%-50.44%-49.72%0.88%60.87%-19.52%10.04%-12.69%
Enterprise Value Growth (3y) (Quarter) -20.08%13.88%29.68%36.42%33.30%24.36%-26.33%30.49%
Enterprise Value Growth (5y) (Quarter) -18.45%
Enterprise Value (QoQ) (Quarter) -138.19%9.33%7.45%11.74%79.05%-404.13%64.97%34.94%-30.30%-1.23%-170.70%57.87%-29.68%32.97%-6.85%-28.70%2.39%16.04%
FCF Margin Growth (1y) (Quarter) -84320.0024,246.00-6528.00-7647.00-14829.00-149455.00-163954.00-247335.00-457227.00
FCF Margin Growth (3y) (Quarter) -556376.00
FCF Margin (QoQ) (Quarter) -100012.0015,211.004,002.00-3521.008,554.00-15564.002,883.00-10703.00-126072.00-30062.00-80499.00-220594.00
Net Margin Growth (1y) (Quarter) 6,616.0020,077.00-15258.002,544.00-12413.00-226961.00-266580.00-302024.00-445470.00
Net Margin Growth (3y) (Quarter) -451266.00
Net Margin (QoQ) (Quarter) -11628.0022,378.00-10369.006,235.001,833.00-12957.007,433.00-8723.00-212715.00-52576.00-28010.00-152169.00
Operating Margin Growth (1y) (Quarter) 5,859.0014,612.00-14271.00-2741.00-14170.00-245893.00-280451.00-323358.00-472864.00
Operating Margin Growth (3y) (Quarter) -481175.00
Operating Margin (QoQ) (Quarter) -6682.0012,174.00-2032.002,399.002,070.00-16709.009,498.00-9030.00-229652.00-51267.00-33409.00-158536.00
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.00-1.00
Return on Assets Growth (3y) (Quarter) 0.000.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -1623.00-1547.00675.002,380.003,931.004,491.004,080.002,199.001,038.00-667.00-4176.00-4149.00-5198.00-5374.00
Return on Capital Employed Growth (3y) (Quarter) 3,346.002,277.00578.00431.00-229.00-1550.00
Return on Capital Employed (QoQ) (Quarter) 214.00-532.00-693.00-612.00290.001,690.001,013.00939.00850.001,278.00-868.00-223.00-854.00-2232.00-841.00-1272.00-1031.00
Return on Equity Growth (1y) (Quarter) -1.00-1.000.000.000.000.000.000.001.000.000.000.000.000.00-1.00-1.00
Return on Equity Growth (3y) (Quarter) 0.000.001.000.000.000.000.000.00
Return on Equity (QoQ) (Quarter) 0.00-1.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Return on Invested Capital Growth (1y) (Quarter) 0.001.000.000.000.000.000.00-1.00-1.00
Return on Invested Capital Growth (3y) (Quarter) 0.00
Return on Invested Capital (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.00
Return on Sales Growth (1y) (Quarter) 1.002.00-2.000.00-1.00-23.00-27.00-30.00-45.00
Return on Sales Growth (3y) (Quarter) -45.00
Return on Sales (QoQ) (Quarter) -1.002.00-1.001.000.00-1.001.00-1.00-21.00-5.00-3.00-15.00